Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Clinical trial NCT00052884 · TERMINATED

Trial details

NCT number: NCT00052884
Sponsor: Eastern Cooperative Oncology Group
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2004-01-22
Primary completion: 2007-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.